← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2014Last known activity
Jun 1, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT03112044Lead sponsorEarly Phase 1Jun 1, 2017
- NCT03166527Lead sponsorPhase 3Jun 1, 2017
- NCT02351011Lead sponsorPhase 1/Phase 2Feb 1, 2015
- NCT02034266Lead sponsorPhase 2Jan 1, 2014
Details
- Last known activity
- Jun 1, 2017